Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 9—September 2003

Dispatch

Paecilomyces lilacinus Vaginitis in an Immunocompetent Patient

Jeanne Carey*Comments to Author , Ron D’Amico*, Deanna A. Sutton†, and Michael G. Rinaldi†‡
Author affiliations: *Beth Israel Medical Center, New York, New York, USA; †University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; ‡Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas, USA

Main Article

Table

Clinical features of cases of Paecilomyces lilacinus infections in immunocompetent hosts

Patient age, gender, and
reference no. Y Type of infection Treatment Outcome
48-year-old woman (our case)
2002
Vaginitis
Iraconazole
Cure
36-year-old man
 (3)
1999
Cutaneous
Itraconazole
Cure
59-year-old woman
 (7)
2001
Cutaneous
Itraconazole
Cure
20-year-old woman (8)
1977
Cutaneous
Griseofulvin
Improvement, but not cure
19-year-old man (9)
1984
Cutaneous
Griseofulvin, then ketoconazole
Improvement
57-year-old man
 (10)
1999
Lung abscess
Surgery
Cure
20-year-old man (11)
1972
Pulmonary effusion
Amphotericin B
Cure
47-year-old woman (12)
1980
Sinusitis
Surgical debridement
Cure
34-year-old man (13)
1997
Endophthalmitis
Fluconazole, ketoconazole, itraconazole
Progression of disease
59-year-old woman (14) 1998 Onychomycosis Terbinafine, various topical therapies, nail clipping Progression of disease

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO